Score Overview
See the full market ranking โ
Aytu BioScience Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 27M to $ 66M and net income went from -$ 13M to -$ 13M. Revenue increased in 3 of those 5 years; net income in 3.
Across Aytu BioScience Inc's full reported history, from 2017 to 2025, revenue grew from $ 3M to $ 66M and net income went from -$ 22M to -$ 13M. Revenue increased in 78% of the years measured; net income in 56%.
Aytu BioScience Inc currently holds a 5-year HDB Score of 5.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.36 | โ |
1 Year2025-08-12 | $ 2.25 | 4.89% |
5 Years2021-08-12 | $ 72.00 | -96.72% |
10 Years2016-08-12 | $ 311.2K | -100.00% |
All Time2017-02-01 | $ 80K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2017-02-01 |
|---|---|---|---|---|---|
| Price | $ 2.36 | $ 2.25 | $ 72.00 | $ 311.2K | $ 80K |
| Return | โ | 4.89% | -96.72% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 62M | -$ 24M | $ 30M |
| 2025 | $ 66M | -$ 13M | $ 30M |
| 2024 | $ 65M | -$ 15M | $ 20M |
| 2023 | $ 107M | -$ 17M | $ 22M |
| 2022 | $ 96M | -$ 108M | $ 19M |
| 2021 | $ 65M | -$ 58M | $ 49M |
| 2020 | $ 27M | -$ 13M | $ 48M |
| 2019 | $ 7M | -$ 47M | $ 11M |
| 2018 | $ 3M | -$ 10M | $ 7M |
| IPO2017 | $ 3M | -$ 22M | $ 802.33K |
Explore beyond AYTU
You're looking at Aytu BioScience Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Bausch Health Companies IncBHCยท revenue grew in 80% of years
- Marker Therapeutics IncMRKRยท revenue grew in 60% of years
- Quest Diagnostics IncorporatedDGXยท revenue grew in 60% of years
- Takeda Pharmaceutical Co Ltd ADRTAKยท revenue grew in 80% of years
- PTC Therapeutics IncPTCTยท revenue grew in 60% of years
